Michel L Tremblay

20PUBLICATIONS
90CO-AUTHORS
Molecular targetsPoverty, inclusivity and wellbeingRegenerative medicine (incl. stem cells)Gene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Apr 15, 2026
PTPN1/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGFβ1 responses.

|Oct 17, 2025
Leishmania donovani's protein tyrosine phosphatases interact with DUF21 and respond to environmental magnesium.

Kayla Paulini, Hira Khursheed, Wen Wei Zhang

|Jul 07, 2025
Impact of culture vessel materials on biomanufacturing of dendritic cell-based immunotherapies in closed systems.

Jiyu Jessica Tian, Hamid Ebrahimi Orimi, Natalie Fekete

|May 09, 2025
PTPN2 Negatively Regulates Macrophage Immune Responses and Cellular Bioenergetics.

Valerie Vinette, Yevgen Zolotarov, Alexandre Poirier

|Oct 30, 2024
PTPN1/2 inhibition promotes muscle stem cell differentiation in Duchenne muscular dystrophy.

Yiyang Liu, Shulei Li, Rebecca Robertson

|Oct 25, 2024
Osteopontin is a therapeutic target that drives breast cancer recurrence.

Yu Gu, Tarek Taifour, Tung Bui

Pageof 4

Frequent Collaborators

2 joint publications

Linda Peltier

2 joint publications

Sung-Hoon Kim

2 joint publications

Chu-Han Feng

2 joint publications

Alexandre Poirier